相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
ARV-110: An androgen receptor PROTAC degrader for prostate cancer
Taavi Neklesa et al.
CANCER RESEARCH (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem et al.
CHEMICAL REVIEWS (2017)
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer
Marcella Bassetto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Androgen receptor antagonists for prostate cancer therapy
Christine Helsen et al.
ENDOCRINE-RELATED CANCER (2014)
Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity
Alexander L. Ruchelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis of aryl nitriles using the stable aryl diazonium silica sulfates
Davood Habibi et al.
JOURNAL OF CHEMICAL RESEARCH (2012)
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-Adrenergic receptor blocking properties
Luiz A. S. Romeiro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: Synthesis, absolute configuration, and in vitro activity
Paul M. Wood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
A. Rodriguez-Gonzalez et al.
ONCOGENE (2008)
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging
Ephraim E. Parent et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
CE Bohl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Androgen replacement therapy - Present and future
LJG Gooren et al.
DRUGS (2004)
Facile synthesis of an azido-labeled thalidomide analogue
SM Capitosti et al.
ORGANIC LETTERS (2003)
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor
D Masiello et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Design, synthesis, and pharmacological characterization of 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]-2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand
ME Van Dort et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
